143 related articles for article (PubMed ID: 24329164)
1. The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler.
Saadat A; Zhu B; Haghi M; King G; Colombo G; Young PM; Traini D
J Pharm Pharmacol; 2014 May; 66(5):639-45. PubMed ID: 24329164
[TBL] [Abstract][Full Text] [Related]
2. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
3. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
4. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Zhu B; Haghi M; Goud M; Young PM; Traini D
Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
6. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
7. Novel simvastatin inhalation formulation and characterisation.
Tulbah AS; Ong HX; Colombo P; Young PM; Traini D
AAPS PharmSciTech; 2014 Aug; 15(4):956-62. PubMed ID: 24806822
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of solution-based pressurised metered-dose inhaler aerosols with an optical particle counter.
Kuhli M; Weiss M; Steckel H
Eur J Pharm Biopharm; 2010 Aug; 75(3):393-8. PubMed ID: 20347974
[TBL] [Abstract][Full Text] [Related]
9. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
Sheth P; Grimes MR; Stein SW; Myrdal PB
Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
[TBL] [Abstract][Full Text] [Related]
10. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
11. A review of the development of Respimat Soft Mist Inhaler.
Dalby R; Spallek M; Voshaar T
Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
[TBL] [Abstract][Full Text] [Related]
12. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
13. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
14. Principles of metered-dose inhaler design.
Newman SP
Respir Care; 2005 Sep; 50(9):1177-90. PubMed ID: 16122401
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler.
Haghi M; Saadat A; Zhu B; Colombo G; King G; Young PM; Traini D
Pharm Res; 2015 Jun; 32(6):2144-53. PubMed ID: 25537341
[TBL] [Abstract][Full Text] [Related]
16. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler.
Ganderton D; Lewis D; Davies R; Meakin B; Church T
Respir Med; 2003 Nov; 97 Suppl D():S4-9. PubMed ID: 14753246
[TBL] [Abstract][Full Text] [Related]
17. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
Jones SA; Martin GP; Brown MB
Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
[TBL] [Abstract][Full Text] [Related]
18. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
19. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
Williams RO; Repka M; Liu J
Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
[TBL] [Abstract][Full Text] [Related]
20. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
Ferguson GT; Hickey AJ; Dwivedi S
Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
